Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Influence of Personality on the Relationship Between Gray Matter Volume and Neuropsychiatric Symptoms in Multiple Sclerosis.
Refractory acute disseminated encephalomyelitis with anti-galactocerebroside antibody.
Clinical use of brain volumetry.
Central Nervous System Expression and PET Imaging of the Translocator Protein in Relapsing-Remitting Experimental Autoimmune Encephalomyelitis.
Novel Therapeutic Approach by Nicotine in Experimental Model of Multiple Sclerosis.
Hospitalization rates and discharge status in multiple sclerosis.
Isoprostanes in clinically isolated syndrome and early multiple sclerosis as biomarkers of tissue damage and predictors of clinical course.
Secondary progression and innate immunity in NMO: A possible link to alemtuzumab therapy?
Exposure to serotonin adversely affects oligodendrocyte development and myelination in vitro.
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis.
Promoting sympathovagal balance in multiple sclerosis; pharmacological, non-pharmacological, and surgical strategies.
Menarche increases relapse risk in pediatric multiple sclerosis.
Differential Sox10 genomic occupancy in myelinating glia.
CONTINUUM Multiple Sclerosis: Teaching Us About More Than MS and Its ABCs.
Tolerogenic dendritic cell vaccines to treat autoimmune diseases: Can the unattainable dream turn into reality?
Prevalence of extracranial venous narrowing on catheter venography in people with multiple sclerosis, their siblings, and unrelated healthy controls: a blinded, case-control study.
Evolution of Quality of Life in Renal Transplant Recipients and Patients With Multiple Sclerosis: A Follow-up Study.
Protective and Detrimental Roles for Regulatory T Cells in a Viral Model for Multiple Sclerosis.
Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis.
The formation of inflammatory demyelinated lesions in cerebral white matter.
Modulating neurotoxicity through CX3CL1/CX3CR1 signaling.
Dual Targeting of the Chemokine Receptors CXCR4 and ACKR3 with Novel Engineered Chemokines.
Paroxetine-Related Adult-Onset Tic Disorder: A Presentation of Primary Progressive Multiple Sclerosis.
Successful Replication of GWAS Hits for Multiple Sclerosis in 10,000 Germans Using the Exome Array.
The ribosomal S6 kinase inhibitor BI-D1870 ameliorated experimental autoimmune encephalomyelitis in mice.
Pages
« first
‹ previous
…
414
415
416
417
418
419
420
421
422
…
next ›
last »